Why the study?
Does plasma BNP measurement accurately identify left ventricular hypertrophy in hypertensive patients in a general population screening context?
Population
1112 volunteers in a health screening program, including a subgroup of 284 hypertensive subjects.
Comparison
Plasma B-type natriuretic peptide measurement vs Echocardiography
Design
Cross-sectional
Authors
Loading...
BNP lacks utility for LVH screening in hypertension; leaves open whether refined thresholds or combinations improve detection in prospective cohorts.
Does plasma BNP measurement accurately identify left ventricular hypertrophy in hypertensive patients in a general population screening context?
Plasma BNP testing has poor discriminatory ability and is of limited use for screening left ventricular hypertrophy among hypertensive patients in the general population.
Motoyuki Nakamura (2003) studied this question.